title: Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
abstract: BACKGROUND
  Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins.
  
  
  OBJECTIVE
  To update guidelines for sclerotherapy of varicose veins.
  
  
  METHODS
  The guidelines for sclerotherapy of varicose veins of the German Society of Phlebology were updated and modified through a review of the available literature.
  
  
  RESULTS
  Published clinical series and controlled clinical trials provide evidence to support the elimination of intracutaneous and subcutaneous varicose veins using sclerotherapy. Allergic skin reactions occur occasionally as allergic dermatitis, contact urticaria, or erythema. Anaphylaxis is rare. Transient migraine headaches present more frequently in patients treated with foam sclerotherapy than liquid sclerotherapy.
  
  
  CONCLUSIONS
  Sclerotherapy is the method of choice for the treatment of small-caliber varicose veins (reticular varicose veins, spider veins). If performed properly, sclerotherapy is an efficient treatment method with a low incidence of complications.
authors.affiliation: Department of Dermatology, University of Bonn, Bonn, Germany. Eberhard.Rabe@ukb.uni-bonn.de
authors.forename: Eberhard
authors.initials: E
authors.lastname: Rabe
authors.forename: Felizitas
authors.initials: F
authors.lastname: Pannier
mesh_terms: D000075202:Contraindications; D005858:Germany; D006801:Humans; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000008:administration & dosage* / Q000009:adverse effects; D012597:Sclerosing Solutions / Q000008:administration & dosage* / Q000009:adverse effects; D015911:Sclerotherapy / Q000009:adverse effects / Q000592:standards*; D014648:Varicose Veins / Q000628:therapy*
chemical_list: D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols